Sonoma Pharmaceuticals (SNOA) Operating Margin: 2011-2012
Historic Operating Margin for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -50.75%.
- Sonoma Pharmaceuticals' Operating Margin rose 6516.00% to -19.21% in Q4 2012 from the same period last year, while for Dec 2012 it was -22.35%, marking a year-over-year increase of 3043.00%. This contributed to the annual value of -50.75% for FY2012, which is 2620.00% up from last year.
- According to the latest figures from FY2012, Sonoma Pharmaceuticals' Operating Margin is -50.75%, which was up 34.05% from -76.94% recorded in FY2011.
- Sonoma Pharmaceuticals' Operating Margin's 5-year high stood at -50.75% during FY2012, with a 5-year trough of -76.94% in FY2011.
- Over the past 2 years, Sonoma Pharmaceuticals' median Operating Margin value was -63.84% (recorded in 2011), while the average stood at -63.84%.
- Data for Sonoma Pharmaceuticals' Operating Margin shows a peak YoY skyrocketed of 2,620bps (in 2012) over the last 5 years.
- Over the past 2 years, Sonoma Pharmaceuticals' Operating Margin (Yearly) stood at -76.94% in 2011, then skyrocketed by 2,620bps to -50.75% in 2012.